Product Information
BROMFENAC SOD 0.075% EYE DROP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $24.3848 per ML under NDC 68180043401. Its NADAC has been published 124 times since May 22, 2024.
FDA first approved this application on Feb 2, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.75 mg/mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180043401
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BROMFENAC SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA211239FDA Approved
2/2/2024
TE Code
AB
On Market Since
2/12/2024
Pharmacological Classes
Price Statistics
The NADAC for BROMFENAC SOD 0.075% EYE DROP has been published 124 times since May 22, 2024, and over the history we have for it it has declined 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $24.3848 per ML |
|---|---|
| All-time high | $26.7005 (Mar 11, 2026) |
| All-time low | $19.7579 (Dec 18, 2024) |
| 52-week high | $26.7005 |
| 52-week low | $23.5416 |
| Median price | $24.0979 |
| Average price | $23.6806 |
| Largest weekly change | -22.0% (Jul 17, 2024) |
| Weeks tracked | 124 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BROMFENAC market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
BROMFENAC market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BROMFENAC SOD 0.075% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for BROMFENAC SOD 0.075% EYE DROP, manufactured by Lupin Pharmaceuticals Inc., is $24.3848 per ML (NDC 68180043401), effective Sep 30, 2026.
How has the price of BROMFENAC SOD 0.075% EYE DROP changed over time?
Over the history we have for it, the NADAC for BROMFENAC SOD 0.075% EYE DROP has declined 2.9%. It has been tracked across 124 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for BROMFENAC SOD 0.075% EYE DROP?
Since May 22, 2024, the NADAC for BROMFENAC SOD 0.075% EYE DROP has ranged from a low of $19.7579 (Dec 18, 2024) to a high of $26.7005 (Mar 11, 2026), with a median of $24.0979 per ML.
Are there cheaper alternatives to BROMFENAC SOD 0.075% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of BROMFENAC SOD 0.075% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BROMFENAC SOD 0.075% EYE DROP?
BROMFENAC SOD 0.075% EYE DROP (NDC 68180043401) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.